(PharmaNewsWire.Com, August 09, 2019 ) The factors driving Advanced Visualization market growth include technological advancements in AV software such as integration of PACS & AV tools, improved diagnostic interpretation with AV tools, rising prevalence of target diseases, and growing demand for advanced diagnostic procedures.
On the basis of type of solution, the market is segmented into enterprise-wide thin client-based solutions and stand-alone workstation-based solutions. In 2016, the enterprise-wide thin client-based solutions is expected to account for the largest share of the market due to offered benefits such as enhanced data storage capacity, data transfer capabilities, multi-user interface, streamlined analysis, and centralized post-processing solutions.
On the basis of imaging modality, the market is segmented into magnetic resonance imaging, computed tomography, positron emission tomography, ultrasound, radiotherapy, nuclear medicine, and other imaging modalities. In 2016, the magnetic resonance imaging segment is expected to command the largest share of the market due to the growing application of MRI in several clinical areas such as oncology, radiology, and cardiology is driving the number of MRI imaging procedures.
On the basis of clinical application, the global advanced visualization industry is segmented into radiology/interventional radiology, cardiology, orthopedics, oncology, vascular, neurology, and other clinical areas (obstetrics/gynaecology, urology, pulmonary, and gastroenterology).
On the basis of end user, the market is segmented into hospitals and surgical centers, imaging centers, academic and research centers, and other end users (pharmaceutical/biotechnology companies and CROs).
On the basis of region, the advanced visualization market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. Dominant position of North America in advanced visualization industry is attributed to the faster adoption of novel diagnostic imaging technologies (as compared to other regions), advancements in the field of advanced visualization technologies, large number of disease diagnostic procedures, and higher preference for advanced visualization solutions for diagnostic imaging.
As of 2015, the global advanced visualization market was dominated by General Electric Company (U.S.), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Toshiba Corporation (Japan), Terarecon, Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Pro Medicus Limited (Australia), Carestream Health, Inc. (U.S.), Agfa-Geveart N.V. (Belgium), and Qi Imaging, LLC (U.S.), among others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
